Burden of rotavirus disease in European Union countries M Soriano-Gabarró, J Mrukowicz, T Vesikari, T Verstraeten The Pediatric infectious disease journal 25 (1), S7-S11, 2006 | 544 | 2006 |
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases T Verstraeten, RL Davis, F DeStefano, TA Lieu, PH Rhodes, SB Black, ... Pediatrics 112 (5), 1039-1048, 2003 | 367 | 2003 |
Vaccinations and risk of central nervous system demyelinating diseases in adults F DeStefano, T Verstraeten, LA Jackson, CA Okoro, P Benson, SB Black, ... Archives of Neurology 60 (4), 504-509, 2003 | 316 | 2003 |
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials D Descamps, K Hardt, B Spiessens, P Izurieta, T Verstraeten, T Breuer, ... Human vaccines 5 (5), 332-340, 2009 | 251 | 2009 |
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines T Verstraeten, D Descamps, MP David, T Zahaf, K Hardt, P Izurieta, ... Vaccine 26 (51), 6630-6638, 2008 | 189 | 2008 |
Prospective multinational study of pertussis infection in hospitalized infants and their household contacts F Kowalzik, AP Barbosa, VR Fernandes, PR Carvalho, ML Avila-Aguero, ... The Pediatric infectious disease journal 26 (3), 238-242, 2007 | 186 | 2007 |
Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review M Bonten, JR Johnson, AHJ van den Biggelaar, L Georgalis, J Geurtsen, ... Clinical Infectious Diseases 72 (7), 1211-1219, 2021 | 182 | 2021 |
The use of combination vaccines has improved timeliness of vaccination in children H Kalies, V Grote, T Verstraeten, L Hessel, HJ Schmitt, R von Kries The Pediatric infectious disease journal 25 (6), 507-512, 2006 | 178 | 2006 |
A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination T Verstraeten, AO Jumaan, JP Mullooly, JF Seward, HS Izurieta, ... Pediatrics 112 (2), e98-e103, 2003 | 135 | 2003 |
Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico FR Velázquez, RE Colindres, C Grajales, MT Hernández, MG Mercadillo, ... The Pediatric infectious disease journal 31 (7), 736-744, 2012 | 131 | 2012 |
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled … PG Kremsner, RAA Guerrero, E Arana-Arri, GJA Martinez, M Bonten, ... The Lancet Infectious Diseases 22 (3), 329-340, 2022 | 120 | 2022 |
Regression models for disease prevalence with diagnostic tests on pools of serum samples S Vansteelandt, E Goetghebeur, T Verstraeten Biometrics 56 (4), 1126-1133, 2000 | 120 | 2000 |
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study T Heikkinen, J Young, E van Beek, H Franke, T Verstraeten, JG Weil, ... American journal of obstetrics and gynecology 207 (3), 177. e1-177. e8, 2012 | 116 | 2012 |
Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005 J Quian, R Rüttimann, C Romero, P Dall’Orso, A Cerisola, T Breuer, ... Archives of disease in childhood 93 (10), 845-850, 2008 | 109 | 2008 |
Rotavirus serotype G9 is associated with more-severe disease in Latin America AC Linhares, T Verstraeten, J Wolleswinkel-van den Bosch, R Clemens, ... Clinical infectious diseases 43 (3), 312-314, 2006 | 105 | 2006 |
A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data K Bollaerts, M Riera-Montes, U Heininger, N Hens, A Souverain, ... Epidemiology & Infection 145 (13), 2666-2677, 2017 | 95 | 2017 |
Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers P Kremsner, P Mann, J Bosch, R Fendel, JJ Gabor, A Kreidenweiss, ... MedRxiv, 2020.11. 09.20228551, 2020 | 93 | 2020 |
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial PG Kremsner, P Mann, A Kroidl, I Leroux-Roels, C Schindler, JJ Gabor, ... Wiener Klinische Wochenschrift 133 (17-18), 931-941, 2021 | 92 | 2021 |
A decade of norovirus disease risk among older adults in upper-middle and high income countries: a systematic review L Lindsay, J Wolter, I De Coster, P Van Damme, T Verstraeten BMC infectious diseases 15, 1-16, 2015 | 92 | 2015 |
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination T Verstraeten, AL Baughman, B Cadwell, L Zanardi, P Haber, RT Chen, ... American journal of epidemiology 154 (11), 1006-1012, 2001 | 86 | 2001 |